Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.
Read Full NewsA groundbreaking study reveals that combining ixekizumab and tirzepatide significantly improves outcomes for adults with psoriatic arthritis and obesity.
Coya Therapeutics reveals promising results for COYA 302, a potential treatment for frontotemporal dementia, showing cognitive stability and Treg enhancement.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the International Stroke Conference (ISC)!
Here's some of what is coming soon to NeurologyLive® this week.
FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.
3.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders
3.
The Danger of Methemoglobinemia and How to Prevent It
4.
Angina Haemorrhagica Bullosa: What You Need to Know
5.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
2.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge